Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) EBIT Margin: 2009-2020

Historic EBIT Margin for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Dec 2020 value amounting to 431.08%.

  • Avadel Pharmaceuticals' EBIT Margin rose 49790.00% to 431.08% in Q4 2020 from the same period last year, while for Dec 2020 it was 36.88%, marking a year-over-year increase of 7760.00%. This contributed to the annual value of 26.04% for FY2020, which is 6676.00% up from last year.
  • Per Avadel Pharmaceuticals' latest filing, its EBIT Margin stood at 431.08% for Q4 2020, which was up 2.57% from 420.28% recorded in Q3 2020.
  • Over the past 5 years, Avadel Pharmaceuticals' EBIT Margin peaked at 431.08% during Q4 2020, and registered a low of -360.52% during Q4 2018.
  • Moreover, its 3-year median value for EBIT Margin was -33.53% (2018), whereas its average is 45.61%.
  • Per our database at Business Quant, Avadel Pharmaceuticals' EBIT Margin slumped by 509,125bps in 2016 and then surged by 49,790bps in 2020.
  • Over the past 5 years, Avadel Pharmaceuticals' EBIT Margin (Quarterly) stood at 39.61% in 2016, then crashed by 5,135bps to -11.74% in 2017, then tumbled by 34,878bps to -360.52% in 2018, then soared by 29,370bps to -66.82% in 2019, then spiked by 49,790bps to 431.08% in 2020.
  • Its last three reported values are 431.08% in Q4 2020, 420.28% for Q3 2020, and 399.06% during Q2 2020.